Reply to "The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective"

J Allergy Clin Immunol Pract. 2021 Feb;9(2):1039-1040. doi: 10.1016/j.jaip.2020.11.056.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Telemedicine*